Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
3.46M
-
Shares change
-
+227K
-
Total reported value, excl. options
-
$17M
-
Value change
-
+$1.21M
-
Number of buys
-
12
-
Number of sells
-
-13
-
Price
-
$4.92
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q3 2022
51 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q3 2022.
Anixa Biosciences Inc - Common Stock (ANIX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.46M shares
of 37.9M outstanding shares and own 9.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.3M shares), UBS Group AG (622K shares), BlackRock Inc. (298K shares), GEODE CAPITAL MANAGEMENT, LLC (271K shares), Long Focus Capital Management, LLC (166K shares), STATE STREET CORP (102K shares), Bank of New York Mellon Corp (97.9K shares), RAYMOND JAMES & ASSOCIATES (60.8K shares), NORTHERN TRUST CORP (58.5K shares), and RENAISSANCE TECHNOLOGIES LLC (57.2K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.